+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Inferior Vena Cava Filter Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

  • PDF Icon

    Report

  • 400 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 6102970
The global inferior vena cava filter market was valued at USD 805.39 Million in 2024 due to the increasing incidence of deep vein thrombosis across the globe. The market is expected to grow at a CAGR of 9.10% during the forecast period 2025-2034 and attain a market value of USD 1.92 billion by 2034.

Global Inferior Vena Cava Filter Market Overview

An inferior vena cava filter also known as an IVC filter is a medical device which is inserted in the inferior vena cava to prevent the blood clots from moving to the lungs. The IVC is a blood vessel that transports oxygen-poor blood from the lower body to the heart. There are various types of IVC filters based on their design and function. These are permanent, retrievable, or temporary filters. Permanent filters are used for long-term protection whereas retrievable filters are removable once the risk subsides. Temporary filters are short-term and taken out following the completion of treatment. These filters are customized for each patient to help avoid clotting in those who cannot use blood thinners or have temporary risk factors.

IVC filter placement is a minimal invasion method. It is done by inserting these filters through a catheter in a vein, usually in the groin or neck. Imaging techniques such as fluoroscopy or ultrasound are used to place them in the inferior vena cava accurately.

Inferior Vena Cava Filter Market Growth Drivers

Rising Deep Vein Thrombosis Prevalence Boosts the Market Significantly

Due to the rising prevalence of deep vein thrombosis (DVT), the global market for inferior vena cava (IVC) filters is also growing. DVT is a condition of blood clot formation in a vein of the leg. According to a study published in 2023, DVT occurs at a rate of 1.6 per 1000 people each year. These rates depend on the different locations such as distal veins, femoral, common femoral, popliteal, and veins. DVTs can occur when a person is immobile for long time periods. People with medical issues such as cancer or an inherited blood disease that is associated with clotting can also experience DVT. Factors like aging population, sedentary lifestyles, obesity, and chronic diseases contribute to the increase in DVT cases and require necessitating preventive measures. IVC filters are implanted in the inferior vena cava to capture the blood clots and prevent complications.

Application of IVC Filters in the Prevention of Pulmonary Embolism to Boost the Global Inferior Vena Cava Filter Market Demand

IVC filters are crucial in the treatment of pulmonary embolisms, a condition in which there are blood clots in the lungs that obstruct blood flow and oxygen levels. IVC interruption devices are essential in stopping bigger pulmonary embolisms that come from the venous system beyond the site where the device is implanted. They serve as a compromise by capturing all clots while keeping the IVC open. Immediate diagnosis and treatment are essential. Generally, low-risk patients are treated with Direct Oral Anticoagulants (DOACs) and discharged, whereas intermediate- and high-risk patients require more intensive treatments such as thrombolysis, thrombectomy, and IVC filters. The rising demand for IVC filters in the global market is driven by the growing popularity of minimally invasive techniques and advancements in healthcare facilities, underscoring the crucial role of these filters in managing PE.

Inferior Vena Cava Filter Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Technological Advancements

Improved filter designs, materials compatible with the body, and less invasive implantation techniques have increased the appeal of IVC filters for patients and medical professionals. Enhanced imaging technologies and digital health tools are increasing the accuracy of filter placement, patient monitoring, and interventions. These innovations enhance the functionality and safety of IVC filters while also broadening their uses to meet changing healthcare demands and improve patient treatment.

Growing Elderly Population

The elderly population, who are at higher risk for chronic diseases such as heart disease and limited movement, are more vulnerable to venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). The demand for IVC filters is increasing as it is being used for preventive measures. The increased demand is prompting healthcare providers and manufacturers to create more specialized filters for the specific requirements of older patients.

Increased Focus on Safety and Efficacy

Concerns about complications like filter migration, perforation, and thrombosis are driving significant innovation and regulatory scrutiny in the market. Manufacturers are putting efforts into advanced materials and design enhancements, such as retrievable filters and increased clot-trapping effectiveness. Regulatory authorities are also implementing more stringent criteria for clinical trials and monitoring after products to guarantee sustained safety and effectiveness.

Increasing Awareness About the Condition

Healthcare professionals and individuals are gaining an increased understanding of the advantages of IVC filters, which results in a stronger emphasis on education and training. Patients are getting educated on the risks of DVT and PE, while professionals are being provided with improved training on insertion and management. Regulatory authorities are also encouraging the safe use of IVC filters. This increased level of awareness is enhancing patient safety, fueling market expansion, and guaranteeing that both patients and healthcare professionals are making informed choices about the utilization of IVC filters.

Inferior Vena Cava Filter Market Segmentation

The report titled “Global Inferior Vena Cava Filter Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:

Market Breakup by Product Type

  • Retrieval
  • Permanent
  • Others

Market Breakup by Application

  • Treatment of Venous Thromboembolism
  • Prevention of Pulmonary Embolism
  • Others

Market Breakup by Material

  • Non-Ferromagnetic Material
  • Ferromagnetic Materials

Market Breakup by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Inferior Vena Cava Filter Market Share

Market Share Based on Product Type to Witness Growth

The market is segmented into retrieval, permanent, and others based on the product type. Among them, the retrieval type is expected to lead the market. Retrieved filters are the filters that can be removed once the risk level goes down, this helps in decreasing the complications. They provide temporary shelter in dangerous situations and are removable once they are no longer necessary. Retrievable filters are popular because of their versatility and reduced risk, resulting in widespread use in the market.

Market Segmentation on the Basis of Material

Based on material, the market is divided into non-ferromagnetic and ferromagnetic materials. Non-ferromagnetic material is expected to lead the market during the forecast years as it does not contain iron which can interfere with magnetic resonance imaging (MRI) and other diagnostic procedures.

Filters made up of non-ferromagnetic materials such as titanium and stainless steel are frequently utilized in IVC filters due to their safety and compatibility. Titanium is chosen for its biocompatibility, lightweight, and resistance to corrosion, while stainless steel provides strength, flexibility, and durability at a more affordable price. Both substances are efficient in prevention of blood clots with low chances of complications.

Inferior Vena Cava Filter Market Analysis by Region

Based on region, the market report covers North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America is expected to dominate the market in the forecast period.

The growth of the North American IVC filter market is driven by elevated healthcare expenditures, sophisticated medical facilities, and rising awareness of preventive healthcare. The United States plays a significant role with a substantial number of patients impacted by cardiovascular diseases, DVT, and PE. Positive reimbursement policies and government initiatives in VTE prevention are also contributing to the increase.

Europe is also poised to have a significant market share propelled by robust healthcare systems and a rising prevalence of cardiovascular diseases. Germany, France, and the United Kingdom are at the forefront with sophisticated infrastructure and significant healthcare investment. The market in the Asia-Pacific region is expanding rapidly which is fueled by the rising prevalence of cardiovascular diseases and aging populations, with China, Japan, and India playing significant roles. Growing knowledge about VTE, economic growth, government efforts, technological progress, and partnerships are broadening market prospects.

Leading Players in the Inferior Vena Cava Filter Market

The key features of the market report include patent analysis, grant analysis, funding, and investment analysis as well as recent partnerships and collaborations by the leading players. The major companies in the market are as follows:

Adient Medical Inc.

Adient is developing absorbable medical devices that safely dissolve in the body once they are no longer needed. It was established in 2012. They concentrate on creating devices that remain effective until they naturally disappear, reducing the necessity for removal operations. In 2022 cordis-X, which is a global frontrunner in the innovation and production of interventional cardiovascular technologies, invested in Adient for their fully absorbable IVC filter, which offers protection against pulmonary embolisms.

Becton, Dickinson and Company

Becton, Dickinson and Company also called as BD, is a U.S.-based multinational corporation specializing in producing and distributing medical equipment, tools, and chemicals. It was established in 1897 with headquarters located in New Jersey, United States. One of the biggest medical technology companies globally, it is enhancing healthcare access worldwide through advancements in medical research, diagnostics, and patient treatment.

Argon Medical

Argon Medical is a top worldwide producer of specialized medical items. It was established in 1972 and has its headquarters in Plano, Texas. They provide a diverse selection of medical equipment for different medical specialities such as interventional radiology, vascular surgery, interventional cardiology, and oncology. The company has a major role in IVC filters and created the Single-Loop and Triple-Loop Retrieval Kits for percutaneous extraction of retrievable inferior vena cava filters through a jugular approach. These kits have a coil-reinforced outer sheath, radiopaque bands for better visibility, and a curved tip for precise control during retrieval.

Cardinal Health

Cardinal Health is a multinational healthcare services company based in the United States that was established in 1971. Based in Ohio, United States, the company focuses on pharmaceutical distribution, manufacturing medical products, and running a vast network of radiopharmacies across the United States.

Other players in the market include ALN, B. Braun Melsungen AG, Braile Biomedica, Cook Medical, Cordis, and Volcano Corporation.

Key Questions Answered in the Inferior Vena Cava Filter Market Report

  • What was the global inferior vena cava filter market value in 2024?
  • What is the global inferior vena cava filter market forecast outlook for 2025-2034?
  • What are the regional markets covered in the report?
  • What is market segmentation based on product type?
  • What is market breakup based on application?
  • What is market segmentation based on material?
  • What are the major end users in the market?
  • What are the major factors aiding the global inferior vena cava filter market demand?
  • How has the market performed so far and how is it anticipated to perform in the coming years?
  • What are the major drivers, opportunities, and restraints in the market?
  • What are the major trends influencing the market?
  • Which country is likely to experience elevated growth during the forecast period?
  • Which regional market is expected to dominate the market share in the forecast period?
  • Who are the key players involved in the global inferior vena cava filter market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Inferior Vena Cava Filter Market Overview
3.1 Global Inferior Vena Cava Filter Market Historical Value (2018-2024)
3.2 Global Inferior Vena Cava Filter Market Forecast Value (2025-2034)
4 Global Inferior Vena Cava Filter Market Landscape*
4.1 Global Inferior Vena Cava Filter Market: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Inferior Vena Cava Filter Market: Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Material
5 Global Inferior Vena Cava Filter Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 PESTEL Analysis
5.3.1 Political
5.3.2 Economic
5.3.3 Social
5.3.4 Technological
5.3.5 Legal
5.3.6 Environment
5.4 Porter’s Five Forces Model
5.4.1 Bargaining Power of Suppliers
5.4.2 Bargaining Power of Buyers
5.4.3 Threat of New Entrants
5.4.4 Threat of Substitutes
5.4.5 Degree of Rivalry
5.5 Key Demand Indicators
5.6 Key Price Indicators
5.7 Industry Events, Initiatives, and Trends
5.8 Value Chain Analysis
6 Global Inferior Vena Cava Filter Market Segmentation (218-2034)
6.1 Global Inferior Vena Cava Filter Market (2018-2034) by Product Type
6.1.1 Market Overview
6.1.2 Retrieval
6.1.3 Permanent
6.1.4 Others
6.2 Global Inferior Vena Cava Filter Market (2018-2034) by Application
6.2.1 Market Overview
6.2.2 Treatment of Venous Thromboembolism
6.2.3 Prevention of Pulmonary Embolism
6.2.4 Others
6.3 Global Inferior Vena Cava Filter Market (2018-2034) by Material
6.3.1 Market Overview
6.3.2 Non-Ferromagnetic Material
6.3.3 Ferromagnetic Materials
6.4 Global Inferior Vena Cava Filter Market (2018-2034) by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Ambulatory Surgical Centers
6.4.4 Others
6.5 Global Inferior Vena Cava Filter Market (2018-2034) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Inferior Vena Cava Filter Market (218-2034)
7.1 North America Inferior Vena Cava Filter Market (2018-2034) by Product Type
7.1.1 Market Overview
7.1.2 Retrieval
7.1.3 Permanent
7.1.4 Others
7.2 North America Inferior Vena Cava Filter Market (2018-2034) by Application
7.2.1 Market Overview
7.2.2 Treatment of Venous Thromboembolism
7.2.3 Prevention of Pulmonary Embolism
7.2.4 Others
7.3 North America Inferior Vena Cava Filter Market (2018-2034) by Material
7.3.1 Market Overview
7.3.2 Non-Ferromagnetic Material
7.3.3 Ferromagnetic Materials
7.4 North America Inferior Vena Cava Filter Market (2018-2034) by End User
7.4.1 Market Overview
7.4.2 Hospitals
7.4.3 Ambulatory Surgical Centers
7.4.4 Others
7.5 North America Inferior Vena Cava Filter Market (2018-2034) by Country
7.5.1 United States of America
7.5.2 Canada
8 Europe Inferior Vena Cava Filter Market (218-2034)
8.1 Europe Inferior Vena Cava Filter Market (2018-2034) by Product Type
8.1.1 Market Overview
8.1.2 Retrieval
8.1.3 Permanent
8.1.4 Others
8.2 Europe Inferior Vena Cava Filter Market (2018-2034) by Application
8.2.1 Market Overview
8.2.2 Treatment of Venous Thromboembolism
8.2.3 Prevention of Pulmonary Embolism
8.2.4 Others
8.3 Europe Inferior Vena Cava Filter Market (2018-2034) by Material
8.3.1 Market Overview
8.3.2 Non-Ferromagnetic Material
8.3.3 Ferromagnetic Materials
8.4 Europe Inferior Vena Cava Filter Market (2018-2034) by End User
8.4.1 Market Overview
8.4.2 Hospitals
8.4.3 Ambulatory Surgical Centers
8.4.4 Others
8.5 Europe Inferior Vena Cava Filter Market (2018-2034) by Country
8.5.1 United Kingdom
8.5.2 Germany
8.5.3 France
8.5.4 Italy
8.5.5 Others
9 Asia Pacific Inferior Vena Cava Filter Market (218-2034)
9.1 Asia Pacific Inferior Vena Cava Filter Market (2018-2034) by Product Type
9.1.1 Market Overview
9.1.2 Retrieval
9.1.3 Permanent
9.1.4 Others
9.2 Asia Pacific Inferior Vena Cava Filter Market (2018-2034) by Application
9.2.1 Market Overview
9.2.2 Treatment of Venous Thromboembolism
9.2.3 Prevention of Pulmonary Embolism
9.2.4 Others
9.3 Asia Pacific Inferior Vena Cava Filter Market (2018-2034) by Material
9.3.1 Market Overview
9.3.2 Non-Ferromagnetic Material
9.3.3 Ferromagnetic Materials
9.4 Asia Pacific Inferior Vena Cava Filter Market (2018-2034) by End User
9.4.1 Market Overview
9.4.2 Hospitals
9.4.3 Ambulatory Surgical Centers
9.4.4 Others
9.5 Asia Pacific Inferior Vena Cava Filter Market (2018-2034) by Country
9.5.1 China
9.5.2 Japan
9.5.3 India
9.5.4 ASEAN
9.5.5 Australia
9.5.6 Others
10 Latin America Inferior Vena Cava Filter Market (218-2034)
10.1 Latin America Inferior Vena Cava Filter Market (2018-2034) by Product Type
10.1.1 Market Overview
10.1.2 Retrieval
10.1.3 Permanent
10.1.4 Others
10.2 Latin America Inferior Vena Cava Filter Market (2018-2034) by Application
10.2.1 Market Overview
10.2.2 Treatment of Venous Thromboembolism
10.2.3 Prevention of Pulmonary Embolism
10.2.4 Others
10.3 Latin America Inferior Vena Cava Filter Market (2018-2034) by Material
10.3.1 Market Overview
10.3.2 Non-Ferromagnetic Material
10.3.3 Ferromagnetic Materials
10.4 Latin America Inferior Vena Cava Filter Market (2018-2034) by End User
10.4.1 Market Overview
10.4.2 Hospitals
10.4.3 Ambulatory Surgical Centers
10.4.4 Others
10.5 Latin America Inferior Vena Cava Filter Market (2018-2034) by Country
10.5.1 Brazil
10.5.2 Argentina
10.5.3 Mexico
10.5.4 Others
11 Middle East and Africa Inferior Vena Cava Filter Market (218-2034)
11.1 Middle East and Africa Inferior Vena Cava Filter Market (2018-2034) by Product Type
11.1.1 Market Overview
11.1.2 Retrieval
11.1.3 Permanent
11.1.4 Others
11.2 Middle East and Africa Inferior Vena Cava Filter Market (2018-2034) by Application
11.2.1 Market Overview
11.2.2 Treatment of Venous Thromboembolism
11.2.3 Prevention of Pulmonary Embolism
11.2.4 Others
11.3 Middle East & Africa Inferior Vena Cava Filter Market (2018-2034) by Material
11.3.1 Market Overview
11.3.2 Non-Ferromagnetic Material
11.3.3 Ferromagnetic Materials
11.4 Middle East & Africa Inferior Vena Cava Filter Market (2018-2034) by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Ambulatory Surgical Centers
11.4.4 Others
11.5 Middle East and Africa Inferior Vena Cava Filter Market (2018-2034) by Country
11.5.1 Saudi Arabia
11.5.2 United Arab Emirates
11.5.3 Nigeria
11.5.4 South Africa
11.5.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.2 US FDA
12.3 EU EMA
12.4 INDIA CDSCO
12.5 JAPAN PMDA
12.6 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia Pacific
17.1.5 Market Share Analysis: Others
17.2 Adient Medical Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Company News and Developments
17.2.5 Certifications
17.3 Argon Medical
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Company News and Developments
17.3.5 Certifications
17.4 B. Braun Melsungen AG
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Company News and Developments
17.4.5 Certifications
17.5 Becton, Dickinson and Company
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Company News and Developments
17.5.5 Certifications
17.6 Braile Biomedica
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Company News and Developments
17.6.5 Certifications
17.7 Cardinal Health
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Company News and Developments
17.7.5 Certifications
17.8 Cook Medical
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Company News and Developments
17.8.5 Certifications
17.9 Cordis
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Company News and Developments
17.9.5 Certifications
17.10 Volcano Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Company News and Developments
17.10.5 Certifications
18 Global Inferior Vena Cava Filter Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)

Companies Mentioned

  • Adient Medical Inc.
  • Becton, Dickinson and Company
  • Argon Medical
  • Cardinal Health

Table Information